Summary
This regulation establishes comprehensive drug and alcohol surveillance, testing, and treatment programs within federal prisons and contract community treatment centers. It mandates urine testing for high-risk inmates and random populations, prescribes detailed collection procedures, requires drug counseling for certain inmates, creates a Residential Drug Abuse Program (RDAP) with specific admission criteria and components, ties program participation to privileges and early release incentives, and imposes disciplinary actions for positive tests or refusal.
Reason
The regulation imposes massive administrative costs through prescriptive testing protocols, mandatory counseling quotas, and complex documentation requirements that divert prison resources from core security functions. Its coercive structure—punishing positive tests with loss of privileges and tying treatment to early release—creates perverse incentives that undermine genuine rehabilitation. The one-size-fits-all federal mandates eliminate local adaptability, preventing prisons from tailoring programs to their specific populations and constraints. The hidden tax on prison budgets, staff time, and inmate compliance is vast, while the effectiveness of such centralized, compulsory programs is dubious compared to decentralized, voluntary approaches. The regulation exemplifies bureaucratic mission creep, expanding the Bureau's reach into criminal justice outcomes that should be decided by judges, not prison administrators.